[The correlation between P-glycoprotein and multidrug resistance of squamous carcinoma in oral and maxillofacial region].
To study the mechanism of drug resistance of oral carcinoma to chemotherapy. 40 cases of squamous carcinoma in the oral and maxillofacial region were examined for the multidrug resistance gene product P-glycoprotein using a monoclonal antibody MRK16. P-glycoprotein was detected in 62.5% of the sample. P-glycoprotein expression was related to the chemotherapy and the degree of differentiation. P-glycoprotein expression was higher in post-chemotherapy group than in unchemotherapy group (P < 0.05). Well differentiated tumors expressed P-glycoprotein more frequently (P < 0.05). P-glycoprotein expression was compared with clinic response to chemotherapy. The accuracy rate of prediction is 75%. P-glycoprotein plays an important role in mechanism of multidrug resistance of squamous carcinoma in the oral and maxillofacial region.